Patents Assigned to Celgene Cellular Therapeutics
  • TUMOR SUPPRESSION USING HUMAN PLACENTAL PERFUSATE AND HUMAN PLACENTA-DERIVED INTERMEDIATE NATURAL KILLER CELLS
    Publication number: 20090252710
    Abstract: Provided herein are placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof. Also provided herein are compositions comprising the same, and methods of using placental perfusate, placental perfusate cells, and placenta-derived intermediate natural killer cells, and combinations thereof, to suppress the growth or proliferation of tumor cells, cancer cells, and the like, and to treat individuals having tumor cells.
    Type: Application
    Filed: September 29, 2008
    Publication date: October 8, 2009
    Applicant: Celgene Cellular Therapeutics
    Inventors: Xiaokui Zhang, Vanessa R. Voskinarian-Berse, Lin Kang, Neerav Dilip Padliya
  • ANGIOGENIC CELLS FROM HUMAN PLACENTAL PERFUSATE
    Publication number: 20090104164
    Abstract: Provided herein are the production of vasculogenic or angiogenic cells from placental perfusate. Also provided are methods of treating an individual having a cardiac or vascular insufficiency, disease, disorder or condition comprising administering to said individual placental perfusate, placental perfusate cells, or combinations of placental perfusate or perfusate cells with placental or non-placental hematopoietic stem cells or adherent placental stem cells.
    Type: Application
    Filed: September 26, 2008
    Publication date: April 23, 2009
    Applicant: Celgene Cellular Therapeutics
    Inventors: Xiaokui Zhang, Mohammad A. Heidaran, Vanessa R. Voskinarian-Berse, Lin Kang, Henry Rendon Barragan